-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
West Pharmaceutical Services Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate for Q3 2022.
- West Pharmaceutical Services Inc Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was -$8M.
- West Pharmaceutical Services Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $37.5M.
- West Pharmaceutical Services Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$30.8M, a 28.2% increase from 2021.
- West Pharmaceutical Services Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$42.9M, a 640% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)